Ercan Osmani
Anadolu Efes Istanbul
Reclaims roster spot
Osmani (illness) will be available for Friday's game against Dubai, according to Efes' official X account.
ANALYSIS
Osmani sat out Wednesday's victory over Zalgiris with an ailment, but he has recovered and will be back on the roster for Round 17. It remains to be seen, though, whether or not he will fill his usual spot in the starting lineup.
Osmani sat out Wednesday's victory over Zalgiris with an ailment, but he has recovered and will be back on the roster for Round 17. It remains to be seen, though, whether or not he will fill his usual spot in the starting lineup.
EuroLeague Per Game Stats
Per Game
Total
Per 36
EuroLeague Per Game Stats
Loading Per Game Stats...
Game Log
2025
2024
2023
Game Log
Loading Game Log...
Advanced Stats
Loading Advanced Stats...
Anadolu Efes Istanbul Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
More Fantasy News
Should play Friday
Osmani (illness) is expected to play Friday against Dubai, according to Efes' official X account.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Status remains unsettled
Osmani (illness) is uncertain for Friday's game against Dubai, according to euroleaguebasketball.net.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Out for Round 16
Osmani will not play Wednesday against Zalgiris due to an illness, according to Efes' official X account.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Questionable for Round 16
Osmani is uncertain for Wednesday's game against Zalgiris, according to euroleaguebasketball.net.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Goes for 18 points
Osmani had 18 points, six rebounds and three assists in Tuesday's win over Paris Basketball.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.